Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease - Join Clinical Trial NCTNCT06824103
How to Join This Clinical Trial - NCTNCT06824103
Learn how to participate in this PHASE4 trial studying an investigational therapy for Graft vs. Host Disease, Chronic Graft vs. Host Disease, Corticosteroid-refractory Chronic Graft vs. Host Disease. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Graft vs. Host Disease, Chronic Graft vs. Host Disease, Corticosteroid-refractory Chronic Graft vs. Host Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Graft vs. Host Disease, Chronic Graft vs. Host Disease, Corticosteroid-refractory Chronic Graft vs. Host Disease
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE4 - Research study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06824103 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 14 locations. Find a study site near you:
Clinical Research Site
Hefei, Anhui 230001 - China
Status: RECRUITING
Clinical Research Site
Guangzhou, Guangdong 510000 - China
Status: RECRUITING
Clinical Research Site
Guangzhou, Guangdong 510515 - China
Status: RECRUITING
Clinical Research Site
Shijiazhuang, Hebei 050000 - China
Status: RECRUITING
Clinical Research Site
Zhengzhou, Henan 450052 - China
Status: RECRUITING
Clinical Research Site
Wuhan, Hubei 430030 - China
Status: RECRUITING
Clinical Research Site
Hangzhou, Zhejiang 310003 - China
Status: RECRUITING
Clinical Research Site
Wenzhou, Zhejiang 325000 - China
Status: RECRUITING
Clinical Research Site
Beijing, 100034 - China
Status: RECRUITING
Clinical Research Site
Beijing, 100070 - China
Status: RECRUITING
And 4 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE4 clinical trial for Graft vs. Host Disease, Chronic Graft vs. Host Disease, Corticosteroid-refractory Chronic Graft vs. Host Disease:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships